# INPEFA
> **NDA216203** · New Drug Application · Sponsor: LEXICON PHARMS INC · Approved 2023-05-26
## Drug
- **FDA Application Number:** NDA216203
- **Application type:** New Drug Application
- **Brand name:** INPEFA
- **Generic name:** SOTAGLIFLOZIN
- **Active ingredients:** SOTAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEXICON PHARMS INC
- **Manufacturer:** Lexicon Pharmaceuticals, Inc.
- **First approval:** 2023-05-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216203)
---
*MORVS · CC0 1.0*